신천지게임사이트 69.rbh283.top 바로가기 바다이야기 꽁머니 환전, 호게임

알라딘오락실릴게임뜻오리지널바다이야기황금성나비

릴게임천국 56.rbh283.top 바다이야기게임방법

바다 이야기 다운 80.rbh283.top 프라그마틱 순위

무료 황금성게임 93.rbh283.top 바다이야기예시종료

체리게임 0.rbh283.top 무료황금성

릴게임보물섬 79.rbh283.top 온라인오션파라다이스

알라딘릴게임 사이트 35.rbh283.top 바다신2다운로드

알라딘게임랜드 99.rbh283.top 바다이야기게임사이트

야마토무료게임 96.rbh283.top 야마토3게임다운로드후기

빠칭코게임다운로드 2.rbh283.top 꽁머니릴게임

종합릴게임 22.rbh283.top 게임몰 릴게임

몰게임 바다이야기 넥슨 바다이야기 게임 방법 오션파라 다이스 사이트 강원랜드 슬롯머신 추천 성인오락게임 강원랜드 슬롯머신 규칙 야마토사이트 게임황금성 오락실게임 파라다이스 바다이야기 2화 릴게임먹튀검증 골드몽릴게임 팡멀티릴게임 바다이야기 코드 바다이야기 하는법 온라인슬롯 전략 체리게임바둑이 피망로우바둑이 바다이야기 고래 바다이야기게임다운 모바일 바다 이야기 다운 바다이야기먹튀사이트 우주전함 야마토 2202 온라인삼국지 오토 알라딘릴게임오락실 무료슬롯버프 오션파라다이스게임 바다이야기꽁머니환전윈윈 릴게임 5만 오리지날릴게임 바다이야기확률 모바일 바다 이야기 다운 바다이야기 꽁 머니 환전 릴게임바다이야기 릴게임종류 온라인 릴게임 오리지널 바다이야기 강원랜드 슬롯머신 하는법 오리지널야마토 황금성동영상 릴게임신천지사이트 다빈치다운로드 적토마게임 바다이야기공략법 인터넷릴게임 이벤트릴게임 일본빠칭코게임 최신 인터넷게임 야마토3게임다운로드 실시간바둑이 릴온라인 오리지날야마토 종합 릴게임 백경게임랜드 황금성오락실게임 릴게임갓 오션파라 다이스예시 사이다 릴게임 야마토게임방법 신천지예시 체리마스터 릴게임 릴게임 체리마스터 강원랜드슬롯머신 도그하우스 하는법 바다이야기게임 사이트추천 신규릴게임 바다이야기 먹튀 돈 받기 야마토2 온라인 런처 pc릴게임 바다이야기파일 강원랜드 슬롯머신 확률 공개 바다이야기 상어 야마토게임무료다운받기 강원랜드 슬롯머신 잭팟 릴게임골드몽릴게임 슬롯머신 무료체험 인터넷야마토 릴게임팡게임 온라인슬롯머신 슬롯 게임사 추천 무료 야마토게임 릴게임 신천지사이트 릴게임다운 황금성후기 온라인릴게임사이트 오션파라 다이스다운 pc야마토 바다이야기 꽁 머니 환전 프라그마틱 체험 신 천지 게임 일본빠찡꼬 알라딘릴게임장 슬롯 무료스핀 바다이야기 무료 바다이야기 꽁 머니 환전 릴게임 꽁머니 10원 야마토게임 바다이야기 pc용 오락실게임 바다이야기 꽁머니 오락실슬롯머신 강시 오션파라 다이스게임 하는법 야마토2다운로드 온라인오션게임 빠칭코게임다운로드 황금성하는곳 릴게임뜻 신오션파라다이스 야마토다운 슬롯모아 온라인 슬롯 하는 법 슬롯머신 무료체험 온라인오션파라다이스 바다이야기apk 파친코게임 10원야마토 로드할 릴황금성 온라인룰렛 야마토게임 하기 모바일 야마토 황금성배당줄 [Shin-Min Joon, Edaily Reporter] Huons has achieved record quarterly results for the second quarter.



Huons CI. (Image=Huons)



Huons today announced its preliminary earnings for the second quarter of this year, reporting consolidated sales of 156 billion won , operating profit of 13.1 billion won , and net pr다모아릴게임
ofit of 11.8 billion won , reflecting year-on-year increase of 4.7%, 40.3%, and 46.5%, respectively.

Quarterly sales surpassed 150 billion won , setting a new record for the highe화승인더 주식
st quarterly revenue. Operating profit also saw a significant increase compared to the same period last year, continuing the trend of improved profitability following the first quarter.
Huonpc야마토
s showed balanced growth across all business segments in the second quarter, with improved performances from subsidiaries. Both Huons N, a subsidiary specializing in health functional foods that compl채권
eted its spin-off and merger in May, and HuonsLifeSciences, specialized in ethical drug (ETC), successfully turned to profit. Additionally, Pangen Biotech, acquired late last year, was included as Huo야마토2다운로드
ns’ consolidated subsidiary starting this June.
By business segment, the ETC division recorded sales of 69.1 billion won in the second quarter. The division continued its stable growth, led by its metabolic disease drugs and injectable exports, marking a 3.9% increase year-on-year. Notably, injectable exports to North America in the second quarter reached 5.4 billion won , a 51% surge compared to the same period last year.
Sales from the beauty and wellness segment recorded 42.2 billion won , a 13.3% decrease year-on-year. This was due to the transfer of the health functional food business unit’s performance to Huons N, starting last May. Excluding the health functional food business, beauty and wellness sales grew by 7.7% to 37 billion won , driven by strong sales of the continuous glucose monitor system, Dexcom G7.
Huons‘ R&D expenses in Q2 amounted to won 9.8 billion, up 9.8% YOY. Sales from the Contract Manufacturing Organization (CMO) business increased by 7.4% to 20.8 billion won . This growth was driven by a rise in both contract manufacturing for eye drops, following the operation of the new eye drop line at Plant 2, and other pharmaceutical contract services.
In May Huons received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for its products, 1% and 2% multiple-dose vials for lidocaine hydrochloride injection. Huons plans to expand its export portfolio to the U.S. by pursuing new registration for its dental anesthetics.
Huons aims to achieve both sales growth and improved profitability in the second half of the year, with the new injectable product line at Plant 2 scheduled for operation in the third quarter. Additionally its health functional food subsidiary Huons N also saw a 76.7% growth in second quarter sales recording 18.7 billion won .
Huons CEO Song Soo young said, “This record high quarterly performance was driven by the stable growth of its existing businesses and the strong performance of its subsidiaries. With the successful spin off and merger of health functional food business unit and the full scale operation of a new production facility in the second half of the year, we expect to secure both sustained top-line growth and profitability.”
On the same day the board of directors approved a cash dividend of 150 won per share and set the record date for the dividend as August 21, in accordance with the revised Financial Investment Services and Capital Markets Act. The record date, which was previously June 30 was changed to the date after the dividend was announced.
The per share dividend for this interim period has slightly decreased compared to the previous year. Although the dividend per share was determined in consideration of the rapidly changing business environment the company plans to maintain its existing policy of increasing the total annual dividend including the year end dividend by 0% to 30% compared to the previous year.
The capital reserve reduction and reduced dividends approved at this year’s AGM do not apply to the interim dividend but will take effect from the year-end dividend. If the year end payout increases, shareholders are expected to benefit from greater tax exempt dividends.
신민준 (adonis@edaily.co.kr)